The classic inflammatory cytokine IL-6 is increased in the sera of SSc patients and has been associated with multiple organ involvement including skin [57], the occurrence of pulmonary fibrosis [58], FVC decline, and increased mortality [59]. This evidence concerns the gene IL6 and systemic sclerosis.